|
The development of stem cells for therapeutic purposes, including cell therapy and regenerative medicine, is emerging as a major field of pharmaceutical research. Stem-cell technology is also making inroads in drug discovery. This technology offers great potential for understanding disease mechanisms and identifying targets, and for effective toxicology screening. This conference addresses both therapeutic and non-therapeutic stem-cell applications. For companies engaged in cell-therapeutics, the technical aspects of achieving stable stem cell populations, as well as product manufacturing challenges and logistics are addressed. Large pharma are increasingly turning to stem cells to identify targets for drug development and for toxicology testing. Also, they are looking to partner with smaller biotech firms to develop commercially viable regenerative medicine products. Networking and presentations by both will foster this relationship. Experts in stem cell science and applications, as well as policy and bio-business come together to cover the emerging role of stem cells in drug development and therapy. As stem cell science matures, it becomes clear that supply and technology will soon cease to limit product development, and that pharmaceutical companies engaged with stem cells will have a competitive advantage. For those who share this attitude, this is a must-attend event.
Why should you attend this event?
Critical challenges that will be addressed: - UNDERSTAND new processes in stem cell differentiation and expansion
- EVALUATE stem cell applications for drug discovery and predictive toxicology
- FORECAST applicabililty of stem cell technologies for therapeutic potential
- ASSESS commercial viability of cell-based products
- INVESTIGATE strategic partnerships between biotech and pharmaceutical industries
- UNDERSTAND the latest developments in the IP and regulatory landscape
Hear keynote addresses from:
- Diane Harbison, Associate Director, Pfizer
- Alain Vertes, Global Alliance Director, Roche
- Thomas Okarma, CEO, Geron
- Ian Wilmut, Chair of Reproductive Biology, Director, Scottish Centre for Regenerative Medicine
- Elizabeth Hill, Director, Head of Transactions, Cambridge Consultants Ltd
- Gabriel Markson, Lead Analyst Cell Therapy, Cambridge Consultants Ltd
Our expert speaker line-up also includes:
- Esteban Pombo Villar, Head of Strategic Alliance Management EU, Novartis
- Raj Chopra, Global Medical Science Director and Senior Principal Scientist, AstraZeneca
- Ole Dragsbæk Madsen, Director of Research Hagedorn Research Institute, Novo Nordisk
Miriam Bibel, Senior Research Investigator, Novartis Rob Hockney, Director Alliance Management, AstraZeneca Dominique Bonnet, Senior Group Leader, Cancer Research UK Tim Allsopp, Chief Scientific Officer, Stem Cell Sciences Louise Leong, Science Director, Stem Cells for Safer Medicine UK Chikafumi Yokoyama, CEO, ReproCELL Cathy Prescott, Director, Biolatris Karim Nayernia, Chair of Stem Cell Biology, Newcastle University Judit Nagy, Director Proteomics Research, Imperial College London Julian Hitchcock, Senior Solicitor, Mills & Reeves Malcolm Alison, Professor of Stem Cell Biology, Barts & The London Aliki Nichogiannopoulou, European Patent Office Sara Rankin, Reader in Leukocyte and Stem Cell Biology, National Heart & Lung Institute, Imperial College
Who should attend?
Vice Presidents, Directors and Group Leaders from within the biotech or pharmaceutical industry with responsibilities in the following areas: - Drug Discovery
- Target Identification/Validation
- Regenerative Medicine
- Tissue Engineering
- Disease Biology and Profiling
| - Toxicology
- Cancer Stem Cells
- Biopharmaceuticals
- Cell Transplantation
- Drug Design
| - Bioinnovation
- Strategic Partnerships
- Stem Cell Therapy
- ATMP Regulation
- Alliance Management
|
Venue details
. . Crowne Plaza St James London
. 45-51 Buckingham Gate London SW1E 6AF
Tel: +44 (0) 207 834 6655 Fax: +44 (0) 207 6307
www.london.crowneplaza.com
| . . 
|  |
Crowne Plaza St James London is a traditional deluxe hotel right in the heart of the city, perfectly situated for all your business and leisure needs. In the heart of Westminster, it is just a stones throw away from Buckingham Palace, The Houses of Parliament, the London Eye and Victoria Station. The hotel boasts three excellent restaurants. Bistro 51 with British and European cuisine, the Michelin Starred Indian restaurant Quilon serving south coastal Indian food and Bank Westminster with a modern British menu. A beautiful, award-winning, courtyard garden surrounds the Victorian buildings of the Crowne Plaza London St James - a peaceful oasis in the centre of London.
Nearest train stations:
• Victoria Station, 7 minutes’ walk
• Waterloo Station, 10 minutes by car Underground stations
• St James’s Park, 5 minutes’ walk (District and Circle lines)
• Victoria Station, 7 minutes' walk (Victoria, District and Circle lines) From St. James's Park Underground Station to the Hotel Take the main St James’s Park exit and turn left into Petty France Street.
Continue Straight down for 200 yards and at the end turn left into Buckingham Gate SMi discounted rates include Continental Breakfast & VAT
£ 205.63 / Standard room / night for single occupancy
£ 229.13 Executive room / night for single occupancy Book your accommodation at SMi discounted rates by calling us on +44 (0)870 9090 713, sending a fax to +44 (0)870 9090 714 or emailing hotels@smi-online.co.uk.
|
Events Home Page
.jpg)
